Marie-Kristin Tilch

4PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 12, 2026
Trials in progress: CARMAN - study protocol of a randomized controlled, international, multicenter, open-label phase II trial evaluating early treatment intensification in patients with high-risk mantle cell lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with rituximab and ibrutinib and 6 months ibrutinib maintenance as compared to standard of care induction and maintenance.

|Jun 10, 2026
Treatment intensification does not improve outcomes beyond rituximab-based therapy in primary mediastinal B-cell lymphoma: a multicenter retrospective analysis.

|Apr 29, 2022
Struggling with extensive informed consent procedures for cancer trials-is there even a benefit for the patients?

Marie-Kristin Tilch, Melanie Schranz, Alice Moringlane

|Jan 09, 2021
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center.

Marie-Kristin Schwaegermann, Melanie Schranz, Markus Moehler

Pageof 1

Frequent Collaborators

1 joint publications

Stephanie Herold

1 joint publications

Fabian Acker

1 joint publications

Nora Liebers

1 joint publications

Matthias Theobald